| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.22 | 4e-07 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.24 | 4e-07 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.22 | 4e-07 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.24 | 4e-07 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.21 | 7e-07 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.2 | 8e-07 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-06 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.36 | 2e-06 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |